$PATH

Dines Daniel sold $22.5M of PATH

Dines Daniel (CEO and Chairman) sold 1,402,347 shares of UiPath, Inc. (PATH) at $16.07 ($22.54M total) on 2026-08-19 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Dines Daniel
Published Aug 20, 2026, 12:27 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 12:30 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PATH
Bearish
medium confidence
Mentioned
$PATH
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PATHBearishMed
01

Why it matters

The disclosed sale provides fresh data on insider holdings and potential market impact.

02

Market read

Large insider sell may influence short‑term price action and sentiment.

03

What to watch

10b5-1 plans are pre‑arranged and may not reflect current sentiment.

Relevance 6/10Novelty 7/10Timing: post‑market 2026‑08‑19

Background

Form 4 filing discloses insider transactions required by SEC.

Company-level read

Ticker impact

$PATHBearishMedium confidence
Context

CEO Dines Daniel sold 1.4M shares for $22.5M via a 10b5-1 plan.

Expected impact

potential short-term downside pressure

Evidence & confidence

Sale size is material for a mid‑cap and executed under a pre‑arranged plan, suggesting possible concerns.

Market effects

RPA/automation sector may see heightened scrutiny of insider activity.

U.S. tech stocks could experience slight pullback.

Limited to investors tracking UiPath and related automation peers.

Counterpoint

Insider sale could be routine liquidity event, not a bearish signal.

Key entities

  • UiPath, Inc.

    Robotic process automation software provider.

  • Dines Daniel

    CEO and Chairman of UiPath.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PATHMed

A Philippine Telecom’s AI Makeover Tests UiPath’s (PATH) Pitch

UiPath (PATH) announced that PLDT, a Philippine telecom, scaled its use of UiPath's AI platform, improving efficiency and saving thousands of work hours. PATH reported Q2 2027 revenue of $410M, up 13% YoY, and annual recurring revenue of $1.938B, up 12%. The company also introduced new products and reshuffled its executive team. PATH's net new ARR was $37M, and GAAP operating income was $32M, below non-GAAP figures.

$PATHHigh

UiPath (PATH) Stock: Jump as Gartner Recognizes IDP Leadership

UiPath (PATH) stock rose 7.53% to $14.78 after Gartner named it a Leader in Intelligent Document Processing for the second year. The recognition highlights UiPath's role in enterprise automation and document management, with its IXP platform converting complex documents into structured data for workflows.

$PATHMedAI 8/10

UiPath Stock Rises 2.2%—Why Its 89% AI Survey Result Isn’t Revenue Yet

UiPath (PATH) shares rose 2.21% to $13.87 on Thursday, though still down 23.9% from pre-earnings levels. A company-sponsored survey showed 89% of respondents with embedded orchestration met ROI expectations, but this doesn't guarantee revenue growth. Q2 revenue increased 13% to $410M, with ARR up 12% to $1.938B. Management expects Q3 ARR of $1.992B-$1.997B. Investors await evidence of monetization at Investor Day on September 22.

$PATHHigh

Citi Just Upgraded UiPath Stock. Here's Why.

Citi's Yitchuin Wong upgraded UiPath (PATH) to 'Buy' with a $23 price target, citing its AI orchestration role and 60% upside potential. PATH stock has fallen 25% year-to-date after missing Q3 revenue estimates, but Wong sees long-term value in its AI integration and raised full-year revenue outlook to $1.789B, exceeding Zacks' consensus.